Skip to main content

Table 2 Dietary intakes and physical activity in subjects with metabolic syndromea

From: Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in subjects with metabolic syndrome: a randomized clinical trial

Variables

CP group

(n = 22)

QP group

(n = 22)

CQ group

(n = 22)

DP group

(n = 22)

P

Pbaseline

Pbetween groups

Energy, Kcal/day

0.25

0.45

 Week 0

2285.7 ± 35.5

2275.3 ± 42.2

2290.1 ± 38.4

2210.7 ± 40.8

 Week 12

2308.5 ± 38.2

2301.6 ± 30.3

2315.2 ± 31.3

2308.7 ± 40.3

 Pwithin groups

0.56

0.60

0.67

0.85

Carbohydrate, gr/day

0.46

0.31

 Week 0

298.7 ± 4.5

290.3 ± 3.5

285.6 ± 6.5

295.8 ± 7.4

 Week 12

290.4 ± 5.8

286.1 ± 3.8

281.6 ± 4.8

289.1 ± 5.8

 Pwithin groups

0.30

0.70

0.42

0.63

Fat, gr/day

0.91

0.76

 Week 0

70.2 ± 2.1

69.2 ± 3.2

73.2 ± 2.5

71.1 ± 4.1

 Week 12

69.2 ± 2.8

66.2 ± 1.9

71.1 ± 2.1

70.3 ± 4.5

 Pwithin groups

0.30

0.09

0.15

0.45

Protein, gr/day

0.41

0.32

 Week 0

88.2 ± 5.3

87.4 ± 5.6

84.5 ± 3.4

85.2 ± 4.1

 Week 12

86.1 ± 4.3

85.1 ± 4.6

83.6 ± 3.8

84.4 ± 4.5

 Pwithin groups

0.15

0.40

0.60

0.63

Physical activity, MET-h/d

0.71

0.60

 Week 0

26.1 ± 2.6

27.8 ± 3.8

24.9 ± 4.1

28.1 ± 5.1

 Week 12

25.8 ± 2.8

27.1 ± 3.4

25.1 ± 4.4

27.8 ± 5.5

 Pwithin groups

0.41

0.60

0.15

0.24

  1. CP curcumin plus placebo, QP coenzyme Q10 plus placebo, CQ curcumin plus coenzyme Q10, DP double placebo, MET-h metabolic equivalent task hours
  2. aData are expressed as mean ± standard deviation (SD)